Edwards EVOQUE Eos MISCEND Study

Mitral Valve Regurgitation (Degenerative or Functional) Clinical Trial

Official title:
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)

Status Active, not recruiting

Clinical Trial Summary

Study to evaluate the safety and performance of the Edwards EVOQUE Eos mitral valve replacement system

Clinical Trial Description

The study is a multi-center, prospective, single-arm, and non-randomized study designed to evaluate the safety and performance of the Edwards EVOQUE Eos mitral valve replacement system. ;

Study Design

Related Conditions & MeSH terms

Mitral Valve Insufficiency
Mitral Valve Regurgitation (Degenerative or Functional)

Clinical Trial Details

NCT number	NCT02718001
Study type	Interventional
Source	Edwards Lifesciences
Contact
Status	Active, not recruiting
Phase	N/A
Start date	February 6, 2015
Completion date	April 30, 2033

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04919980` - TVMR With the Innovalve System Trial - Early Feasibility Study	Phase 1
Recruiting	`NCT05688514` - TVMR With the Innovalve System Trial - First In Human Israel	N/A
Not yet recruiting	`NCT05263375` - TVMR With the Innovalve System Trial - TWIST-BE TWIST-PILOT-BE	N/A
Recruiting	`NCT05010746` - TVMR With the Innovalve System Trial - Pilot Study in Italy	N/A
Recruiting	`NCT05682066` - TVMR With the Innovalve System Trial - Pilot in Georgia	N/A